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Understanding adeno-associated virus (AAV) trafficking is critical to advance our knowledge of AAV biology and exploit novel
aspects of vector development. Similar to the case for most DNA viruses, after receptor binding and entry, AAV traverses the
cytoplasm and deposits the viral genome in the cell nucleus. In this study, we examined the role of the microtubule (MT) net-
work in productive AAV infection. Using pharmacological reagents (e.g., nocodazole), live-cell imaging, and flow cytometry
analysis, we demonstrated that AAV type 2 (AAV2) transduction was reduced by at least 2-fold in the absence of the MT network.
Cell surface attachment and viral internalization were not dependent on an intact MT network. In treated cells at 2 h postinfec-
tion, quantitative three-dimensional (3D) microscopy determined a reproducible difference in number of intracellular particles
associated with the nuclear membrane or the nucleus compared to that for controls (6 to 7% versus 26 to 30%, respectively).
Confocal microscopy analysis demonstrated a direct association of virions with MTs, further supporting a critical role in AAV
infection. To investigate the underling mechanisms, we employed single-particle tracking (SPT) to monitor the viral movement
in real time. Surprisingly, unlike other DNA viruses (e.g., adenovirus [Ad] and herpes simplex virus [HSV]) that display bidirec-
tional motion on MTs, AAV2 displays only unidirectional movement on MTs toward the nuclei, with peak instantaneous veloci-
ties at 1.5 to 3.5 m/s. This rapid and unidirectional motion on MTs lasts for about 5 to 10 s and results in AAV particles migrat-
ing more than 10 m in the cytoplasm reaching the nucleus very efficiently. Furthermore, electron microscopy analysis
determined that, unlike Ad and HSV, AAV2 particles were transported on MTs within membranous compartments, and surpris-
ingly, the acidification of AAV2-containing endosomes was delayed by the disruption of MTs. These findings together suggest an
as-yet-undescribed model in which after internalization, AAV2 exploits MTs for rapid cytoplasmic trafficking in endosomal
compartments unidirectionally toward the perinuclear region, where most acidification events for viral escape take place.
Adeno-associated virus (AAV), a member of the Parvoviridaefamily, is unique in that it requires helper virus (e.g., adeno-
virus [Ad] or herpes simplex virus [HSV]) for productive replica-
tion. This nonenveloped icosahedral protein capsid (20 nm in
diameter) packages a 4.7-kb single-stranded genomic DNA. The
capsid is composed of three overlapping subunit proteins, en-
coded by the cap gene, at a Vp1/Vp2/Vp3 ratio of 1:1:10. Due to its
unique properties, including nonpathogenicity, ability to trans-
duce dividing and nondividing cells, breadth of tissue tropism,
and sustainable transgene expression, several recombinant AAV
capsids, especially serotype 2 (rAAV2), have been extensively ex-
ploited as gene therapy vectors (54). The potential of this vector
has been well demonstrated by recent successes in several clinical
trials, including treatment of Leber’s congenital amaurosis (30)
and hemophilia B (33). Despite many advances in vector develop-
ment, administration of high-dose viral particles is required to
achieve efficient transduction due to rate-limiting steps, including
preexisting immune responses and nonspecific targeting (39). In
addition to these limitations, the host cell also exploits various
cellular components as barriers to productive AAV infection, in-
cluding the critical steps required for viral trafficking (e.g., cell
surface uptake, cytoplasmic trafficking, endosomal escape, nu-
clear entry, etc.) (53). Better understanding of the AAV cellular
trafficking will advance our knowledge of AAV biology and facil-
itate the development of enhanced AAV vectors.
To successfully transduce a cell, AAV virions have to travel
through a variety of cellular structures and organelles consecu-
tively, including those involved in cell surface binding and inter-
nalization, cytoplasmic trafficking, and finally nuclear entry. It is
known that AAV2 virions bind to their primary receptor, heparan
sulfate proteoglycan (HSPG), on the cell surface (49) and are in-
ternalized through a clathrin-dynamin-mediated pathway (2, 12),
which are facilitated by coreceptors, including integrins (48) and
fibroblast growth factor (FGF) receptors (36). After entry, the vi-
rus remains associated with endosomes until acidification of the
compartment, which triggers exposure of the N terminus of Vp1
protein (46). The N terminus of Vp1 carries phospholipase activ-
ity and facilitates escape of viral particles by breaking down the
endosomal membrane (46). Successful transduction of AAV re-
quires that its genome be delivered into the nucleus, which is
believed to be achieved by nuclear localization signals on the cap-
sid subunit Vp1 (19). However, little is known about how the viral
particles traverse across the dense cytoplasm microenvironment
from the cell periphery to the proximity of the nucleus, where
AAV enters the nucleus.
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Microtubules (MTs) are a component of cytoskeleton and are
rope-like polymers of tubulins. MTs are highly dynamic, as char-
acterized by alternate phases of elongation and shrinkage, and play
critical roles in a variety of cellular processes, including maintain-
ing cell structure, intracellular transportation, and forming the
spindle during mitosis, to name a few (8). Their actions in intra-
cellular transport are usually achieved by either their own growth
dynamics (40) or the activities of associated motor proteins, par-
ticularly kinesin and dynein (29). Numerous studies have shown
that both nonenveloped and enveloped viruses utilize MTs in in-
fecting their host cells. This is typically exemplified by the utiliza-
tion of dynein by viral particles to traffic through the crowded
cytoplasmic environment to the nucleus. For AAV, previous stud-
ies have reported that MT disruption impairs AAV transduction
(41) and that AAV can bind the cytoplasmic dynein in an in vitro
binding assay (25). However, these studies were in contrast to
another publication, which reported that AAV transduction was
not affected by the disrupted MT network or dynein motor activ-
ity (21). As a result, the exact roles of MTs in AAV transduction as
well as the underling mechanisms are yet unclear.
In this study, we have investigated the exact role(s) of MTs in
AAV transduction and corresponding potential mechanisms us-
ing multiple techniques, including confocal microscopy, live-cell
imaging, quantitative three-dimensional (3D) microscopy, phar-
macological reagents, and single-particle tracking (SPT). Data
from live-cell imaging and flow cytometry analysis demonstrated
that the viral transduction was impaired in the presence of several
chemicals used to disrupt MTs. This result was further supported
by the measurements from quantitative microscopy, indicating
that the proportions of AAV particles associated with the nuclear
envelope or inside the nucleus were significantly diminished upon
MT disruption. In single-particle tracking experiments, we ob-
served that AAV virions display three classical types of particle
motions, i.e., confined diffusion, normal diffusion, and directed
motion. For the first time, we demonstrated the fast and unidirec-
tional migration of AAV2 on MTs, with a peak instantaneous
velocity of up to 1.5 to 3.5 m/s, which is consistent with the
motion mediated by the dynein motor. Furthermore, our obser-
vations from electron microscopy and pharmacological studies
determined for the first time that AAV2 traffics on MTs in the
endosomal compartment and that acidification of such structures
is dependent on intact MTs. Together these data strongly support
an as-yet-undocumented model in which AAV2 exploits MTs for
its rapid directed cytoplasmic transportation toward the perinu-
clear sites where acidification of endosomes for viral escape takes
place.
MATERIALS AND METHODS
AAV2 production, purification, and labeling. AAV2 was produced in
HEK-293 cells as previously described (18). Briefly, cells were transfected
with three plasmids, pXR2, pXX680, and pTR-CMV-GFP (containing the
green fluorescent protein [GFP] reporter transgene flanked by two in-
verted terminal repeats (ITRs). At 60 h after transfection, cells were har-
vested and nuclei were isolated using hypotonic buffer and a Kontes ho-
mogenizer (18). AAV2 particles were recovered by resuspending the
nuclear pellet in phosphate-buffered saline (PBS) with 0.5% deoxycholate
(DOC) and then sonicated for 1 min. Highly pure virus was then retrieved
as described previously (55). Briefly, after DNase treatment, the virus
suspension was subjected to one round of cesium chloride (CsCl) step
gradient density fractionation and another round of fractionation using
CsCl continuous gradient density. Determination of peak viral fractions,
dialysis of virus, and measurement of viral titers by quantitative PCR
(qPCR) were done as described previously (18). The infectivity of AAV
has been determined to be about 1 transduction unit per 100 particles.
AAV2 was covalently labeled with Cy5 or 1.4-nm nanogold particles as
described in the manufacturer’s protocol with slight modifications.
Briefly, purified AAV2 was incubated for 2 h at 4°C in PBS with a 20-fold
molar excess of mono-NHS-Cy5 (GE Healthcare) or mono-NHS-nano-
gold (Nanoprobes) over the capsid protein units. Free dyes or nanogold
was removed from labeled viral particles by dialysis against PBS contain-
ing 5% sorbitol, and viral solutions were stored at 80°C as small ali-
quots. The degree of labeling (DOL) of Cy5-AAV2 was determined by
spectrophotometry according to the manufacturer’s instructions. Titers
of labeled virus were determined by both dot blotting (18) and qPCR.
Infectivity of the viral particles was determined by GFP reporter gene
assay.
Cell culture and drug treatment. HeLa cells (American Type Culture
Collection) were grown in Dulbecco’s modified Eagle medium (DMEM)
(Invitrogen) with 10% fetal bovine serum (FBS) in a 5% CO2 incubator.
All cells were passaged every 2 to 3 days for up to 10 passages, and new
aliquots of frozen cells were recovered from liquid nitrogen. To disrupt
microtubules, the cells were incubated with medium containing 30 M
nocodazole or 10 M vinblastine for 30 to 60 min before experiments. For
lysosomotropic reagents, 50 M chloroquine or 64 nM bafilomycin A1
was administered to block the acidification of endosomes. The drugs were
maintained in the culture throughout the experiments.
Pulse infection and immunofluorescence. Pulse infection with AAV2
was performed as previously described (55). Briefly, HeLa cells were
seeded on 12-mm glass coverslips at 24 h before infection. The next day,
after incubation in DMEM containing 20 mM HEPES at 4°C for 5 min,
cells were inoculated with Cy5-AAV2 (5,000 viral genomes [vgs]/cell) at
4°C for another 40 min. Cells were washed with PBS to remove unbound
virions and transferred to a 37°C incubator (this was regarded as 0 h
postinfection [p.i.]).
For immunofluorescence, cells were washed with PBS and then fixed
with 4% paraformaldehyde (PFA) for 15 min at room temperature (RT).
The cells were then permeabilized with 0.2% Triton X-100 in PBS for 5
min at RT. After blocking with immunofluorescence buffer (IFB) (5%
normal goat serum in PBS containing 0.05% Tween 20) for 1 h at RT, the
cells were incubated with primary antibody to detect tubulin (rat mono-
clonal antibody from Abcam Inc.), diluted in 50% IFB, overnight at 4°C.
The cells were then incubated in secondary antibody, diluted 1:2,000 in
50% IFB (anti-mouse Alexa-Fluor 488 [Molecular Probes]), for 1 h at RT.
After six washes with PBS, coverslips were mounted cell side down on
glass slides with mounting medium (Prolong Antifade Gold with DAPI
[4=,6=-diamidino-2-phenylindole]; Molecular Probes).
Reporter gene assay and live-cell imaging. At 3 h after pulse infection
with self-complementary AAV2 containing TR-CMV-GPF, HeLa cells
were transferred to the stage of an Olympus IX-70 instrument for record-
ing the GFP expression in real time. The camera was set to take a frame of
GFP expression in dimethyl sulfoxide (DMSO)- or nocodazole-treated
cells every 5 min. The snapshots of GFP expression were taken at the
indicated time points from the video, and the level of GFP expression was
measured by the mean fluorescence intensity (MFI) of GFP using the
Image J program.
Quantitative 3D microscopy. HeLa cells pulse infected with Cy5-
AAV2 were fixed with PFA and mounted on glass slides as described
above. The distribution of viral particles in HeLa cells was examined using
a Zeiss LSM710 laser scanning confocal microscope equipped with a Plan-
Apochromat 63 1.40-numerical aperture (NA) oil objective. Stacks of
20 to 30 focal planes were captured at 0.31-m z intervals through the
depth of the cell. 3D images of the cells were reconstructed by using the
image stacks. All images were acquired at pixel dimensions of 0.13 by 0.13
by 0.31 m (x, y, and z, respectively) to fulfill the Nyquist sampling.
Deconvolution was performed with AutoDeblur software (Media Cy-
bernetics Inc.) using iterative and constrained algorithms as described
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previously (55). The procedure started with a theoretical point spread
function (PSF) derived from the actual setting of the Zeiss 710 confocal
microscope, including the NA of the microscope objective, refractive in-
dex of the medium, excitation wavelength, emission wavelength, confocal
pinhole radius, pixel size, z-axis interval, and microscope type (i.e., wide
field, confocal). A new adjusted adaptive PSF derived from the previous
deconvolution round was used to generate the next adaptive PSF that fit
the real imaging data better than the previous one (termed one iteration or
deconvolution round). A 12-round iteration was used to deconvolve all
the confocal images in this study.
All deconvolved image stacks was processed using the IMARIS soft-
ware package (Bitplane AG, Zurich, Switzerland) for visualization and
quantification as described previously (55). Briefly, each deconvolved im-
age stack was reconstructed using a volume-rendering module and
smoothed by a 3D median filter. Subsequently, an isosurface-rendering
module was applied through thresholding by the fluorescence intensity
that is slightly higher than background. For Cy5-AAV2, the isosurface
rendering was thresholded at the fluorescence intensity of 1,500 arbitrary
units (a.u.) (the upper boundary of background). For DAPI, isosurface
rendering was thresholded at the fluorescence intensity of 2,900 a.u. Pa-
rameters (volume, MFI, and total fluorescence intensity [TFI]) for these
isosurface-coated Cy5-AAV2 objects were extracted from the IMARIS
program and analyzed to determine the localization of particles as de-
scribed previously (55).
Internalization assay. Pulse infection and immunofluorescence were
carried out on HeLa cells as described above, except that the cells were not
permeabilized when incubating with mouse monoclonal antibody A20 to
specifically probe the viral capsids on cell surface. The colocalization be-
tween A20 and Cy5 signal was examined by 3D microscopy as described
above. In this scenario, A20-positive Cy5-AAV2 presents the virion on cell
surface, and A20-negative Cy5-AAV2 presents the virion inside the cells.
Single-particle tracking and analysis. For fluorescence imaging,
HeLa cells were cultured in phenol red-free DMEM with 10% FBS in petri
dishes with poly-L-lysine-coated glass coverslips on the bottom. Before
fluorescence experiments, cells were washed in serum-free, phenol red-
free medium supplemented with 20 mM HEPES (pH 8.0). The movement
of Cy5-AAV2 particles was recorded with an Olympus IX-81 microscope
equipped with a Hammatsu camera.
The trajectories of AAV particles were generated by the “cell” module
in the IMARIS program. The location of each viral particle was computed
as the centroid of the bright spot. The parameters (instantaneous speed,
displacement, and displacement length) of the viral trajectories were di-
rectly extracted from the program as follows: instantaneous speed at time
index t, St  Dxt,t  1
2  Dyt,t  12
Tt  Tt  1
, with Dx(t1,t2)  Px(t1) 
Px(t2) where T(t) is time in seconds at time point t and Px(t) is the x
position of the particle at time index t; displacement of particle at time t
after initial time point t0, D
2(t)  Dx
2(t0  t,t0)  Dy
2(t0  t,t0);
and displacement length of a viral trajectory, DtL,t0 
DxtL,t02DytL,t02, where tL is the last time index of the trajectory.
Mean square displacement (MSD) plot analysis was carried out as
described previously (1, 7). For each trajectory of an AAV particle, the




Nn1 Dxi·t  n·t,i·t2  Dyi·t 
n·t,i·t2, where N is the total number of frames in the video, t is the
time interval between two successive frames, and n and i are positive
integers.
TEM. For negative staining of AAV2 and nanogold-AAV2, viral par-
ticles in PBS were pipetted onto a glow-discharged copper grid. The grid
was washed twice with water and then stained with 2% uranyl acetate. For
visualizing nanogold-AAV2 in cells, infected HeLa cells were fixed at
room temperature in 2% glutaraldehyde (in 0.15 M sodium phosphate
buffer, pH 7.4) for 20 to 30 min, followed by 1 h in 1% OsO4. Silver
enhancement was applied on the ultrathin sections. Electron microscopy
images were taken with an LEO EM910 transmission electron microscope
(TEM) at various magnifications.
RESULTS
Microtubule disruption impairs AAV2 transduction. The mi-
crotubule (MT) network has been shown to be required for suc-
cessful infection and replication of viruses, including canine par-
vovirus (CPV) and bovine parvovirus (BPV). To investigate the
role of MTs in AAV infection, we first examined whether MT
disruption affects viral transduction. Recombinant AAV2
(rAAV2) carrying a self-complementary GFP transgene cassette
was used in reporter gene assays to evaluate the level of viral trans-
duction. Self-complementary AAV2 (scAAV2) was designed to
overcome the step of second-strand synthesis of viral DNA for
successful transduction (31). AAV2 particles were incubated with
cells at 4°C for about 40 min, and unbound particles were then
removed by washing before cells were transferred to 37°C for sub-
sequent viral events. This procedure is defined as “pulse infection”
to synchronize viral infection, which was used in all experiments
throughout this study. In this study, we used mean fluorescence
intensity (MFI), reflecting the average number of GFP molecules
per cell, to measure the level of AAV2 transduction. To better
understand the viral transduction profiles, videos were taken on
an IX70 microscope to record the expression of the viral GFP
transgene in real time. Briefly, at 3 h after pulse infection with
scAAV2-GFP, HeLa cells were transferred to the microscope stage
for live imaging up to 21 h p.i. (see Movies S1 and S2 in the
supplemental material). Snapshots were taken from the videos at 3
h, 6 h, 8 h, 12 h, 16 h, and 21 h after infection (Fig. 1A). The GFP
expression by AAV2 could be detected as early as 6 to 8 h p.i. in
DMSO-treated cells but was only barely detectable at 8 h p.i. in
nocodazole-treated cells. The quantitative data on the GFP mean
fluorescence intensity (MFI) agree with this observation (Fig. 1B).
To test whether nocodazole reduces AAV transduction in a viral
dose-dependent manner, different multiplicities of infection
(MOIs) of AAV were used to pulse infect the HeLa cells in the
presence of nocodazole or DMSO and GFP expression was mea-
sured by flow cytometry. To exclude the potential effects of dead
cells on the quantification, we washed the cells in each well three
times with PBS before harvesting them for flow cytometry analysis
to remove any floating or loosely attached cells (which typically
are dead ones). With this experimental procedure, we ensured
that about 95% of the cells subjected to flow cytometry analysis
were viable (data not shown). The histogram in Fig. 1C demon-
strates that nocodazole treatment before AAV inoculation re-
duced the viral transduction at all tested dosages from 80 vgs/cell
to 10,000 vgs/cell (Fig. 1C; see Fig. S1 in the supplemental mate-
rial). There was no significant difference between pulse infections
at 37°C and at 4°C in regard to the reduction of viral transduction
by nocodazole treatment (Fig. 1C; see Fig. S2 in the supplemental
material).
Nocodazole-induced MT disassembly could have reduced the
viral transduction by impairing either the viral trafficking or the
promoter activity of the transgene cassette. To examine the poten-
tial effects of nocodazole on the promoter activity of the AAV
transgene cassette, we measured the GFP expression from plasmid
transfection of a corresponding transgene cassette in AAV in the
presence of DMSO or nocodazole. Our data show that level of GFP
expression from plasmid transfection in the nocodazole-treated
cells is not significantly different from that in DMSO-treated cells
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(see Fig. S3 in the supplemental material). This observation sug-
gests that nocodazole treatment does not alter the activity of the
promoter in the transgene cassette but instead affects the AAV
transduction, most probably at the level of viral trafficking or pro-
cessing. Importantly, the reduction of viral transduction was not
limited to the nocodazole treatment but was also observed with
other MT disassembly drugs, including colchicine and vinblastine
(see Fig. S4 in the supplemental material). This result further dem-
onstrates that it is MT disruption and not a side effect of nocoda-
zole that impairs the viral transduction.
AAV2 attachment and internalization on the cell surface are
not affected by MT disruption. MTs have been previously dem-
onstrated to be critical for clathrin-dynamin-mediated viral entry
as well as cytoplasmic trafficking of viruses (6, 15, 16, 51). Here we
examined whether intact MTs are required for the attachment and
internalization of AAV2 particles on the cell surface. Immediately
after pulse infection, cells were harvested and subjected to viral
genome extraction. The average number of viral genomes per cell
was measured by quantitative PCR (Fig. 2A). The histogram in
Fig. 2A shows that the amount of viral particles attached to the
nocodazole-treated cells is comparable to that attached to control
cells, demonstrating that an intact MT network is not required for
cell surface binding of AAV2. To test whether internalization of
AAV2 particles was affected by the disruption of MTs, we em-
ployed both Cy5-AAV2 particles and a mouse monoclonal anti-
body, A20, which can specifically recognize intact viral particles.
For immunofluorescence on the cells with an intact cell mem-
brane before permeabilization, antibody will not be able to enter
the cell and will probe only the viral particles on cell surface. Un-
der this scenario, HeLa cells were pulse infected with Cy5-AAV2
and fixed with paraformaldehyde at 0 h or 1 h after infection.
Without permeabilization, cells were probed with A20 antibody
and colocalization between Cy5 and A20 signal was imaged with
confocal microscopy (Fig. 2B). The Cy5 signal represents all the
viral particles on the cell surface and inside the cells, and the A20
signal highlights only the viral particles on the cell surface. As a
result, A20-positive Cy5-AAV2 particles are on the cell surface
and A20-negative Cy5-AAV2 particles are internalized inside the
cells (Fig. 2C). Maximum-intensity projection (MIP) was applied
to display 3D information of colocalization between A20 and Cy5
signals in 2D images (Fig. 2B). Figure 2B shows that almost all
Cy5-AAV2 particles were also stained with A20 antibody on both
control and nocodazole-treated cells at 0 h after infection, which is
consistent with the fact that almost all viral particles should be on
the cell surface without internalization at 0 h p.i. At 1 h p.i., the
majority of Cy5-AAV2 particles were not stained with A20 anti-
body and only about 12% of viral particles were stained with A20
in the nocodazole-treated cells, a level which is comparable to that
in control cells (Fig. 2B and C). These data determine that neither
binding nor internalization of AAV2 particles on the cell surface is
dependent on an intact MT network.
MT disruption reduces the perinuclear accumulation and
nuclear entry of AAV2. The above-described results demonstrate
that MT disruption before viral inoculation reduced the viral
FIG 1 Microtubule disruption before viral inoculation reduces early AAV2 transduction. At 30 to 60 min after pretreatment with DMSO or nocodazole, HeLa
cells were incubated with AAV2-CMV-GFPsc (scAAV2-GFP) particles at 4°C for 40 min, and unbound virions were washed out before transferring HeLa cells
to 37°C (“pulse infection”). A video of the GFP expression was taken from 3 h to 21 h after pulse infection. (A) Snapshots of the video were taken at 3, 6, 8, 12,
16, and 21 h p.i. (B) Quantification of GFP fluorescence intensity in the snapshots with Image J. (C) HeLa cells were treated with DMSO or nocodazole at 30 to
60 min before pulse infection with scAAV2-GFP at different dosages (80, 400, 2,000, and 10,000 vgs/cell). GFP expression was measured by flow cytometry at 11
h p.i., and mean fluorescence intensity (MFI) was normalized to that of DMSO treatment. The normalized ratio of the percentage of GFP-positive cells is shown
in Fig. S1 in the supplemental material.
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transduction by at least 2-fold and that neither viral attachment
nor internalization was impaired by nocodazole treatment, sug-
gesting that the reduced transduction is more likely caused by
altered viral trafficking or processing (i.e., cytoplasmic trafficking
or nuclear entry). For most DNA viruses, cytoplasmic trafficking
from the cell periphery to the perinuclear region is critical for the
nuclear entry of viral components. As nuclear entry of AAV2 is
known to be a prerequisite for successful viral transduction, we
examined the efficiency of these events under nocodazole or
DMSO treatment. Here, we used Cy5-AAV2 particles generated
by covalent labeling of purified AAV2 capsids with Cy5 fluoro-
phores as described previously (55). After pretreatment with no-
codazole or DMSO for 30 to 60 min to allow full disruption of
MTs by nocodazole, HeLa cells were pulse infected with Cy5-
AAV2 and the localization of viral particles was examined at 2 h
p.i. using confocal fluorescence microscopy (Fig. 3; see Movies S3
and S4 in the supplemental material). Figure 3A shows a represen-
tative distribution of AAV2 particles upon DMSO or nocodazole
treatment for 2 h. To quantify such a distribution, we used 3D
quantitative microscopy as described previously (55), and Fig. 3B
shows representative images to illustrate the actual quantification
by presenting the views from different angles of the 3D images
(Fig. 3B; see Movies S3 and S4 in the supplemental material). The
quantitative data are presented in Fig. 3C. In DMSO-treated cells,
AAV2 particles were distributed normally; i.e., about half of the
intracellular particles localized at the nuclear periphery, 10 to 15%
were in the nucleus (with 39 particles per nucleus on average), and
the remaining particles were in the cytoplasm (Fig. 3B and C). In
the cells where MTs were fully disrupted by nocodazole, only
about 3% of viral particles were in the nucleus (about 12 particles
per nucleus on average), and the remaining 97% of the particles
were scattered across the cytoplasm (Fig. 3B and C). In the aspect
of nuclear targeting, viral particles seem to get lost in the cyto-
plasm and randomly localize in the nocodazole-treated cells. It is
known that the nuclear envelope is one of the cellular structures
that AAV2 particles have to interact with before their nuclear en-
try. Figure 3 clearly shows that a much smaller proportion of in-
tracellular AAV2 virions localized at the perinuclear region in the
nocodazole-treated cells than in the DMSO-treated cells (Fig. 3A
and B). We then tested whether reduced perinuclear localization
of AAV2 had led to a reduced proportion of virions associated
with the nuclear membrane. Using the quantification method es-
tablished previously (55), we determined that only about 3% of
AAV2 particles associated with the nuclear membrane in the no-
codazole-treated cells, compared to over 10% in the control cells
(Fig. 3C). These data suggest that the cytoplasmic trafficking from
the cell periphery to the perinuclear region may facilitate interac-
tion of the virus with the nuclear membrane. All of these data
support a model where MT disruption reduces the proportions of
AAV2 particles in the perinuclear and nuclear regions and thus
reduces the viral transduction.
AAV2 exploits MTs for rapid and unidirectional trafficking
from cell periphery to perinuclear region. The reduced perinu-
clear accumulation and nuclear entry are most likely caused by the
impaired MT-mediated cytoplasmic trafficking, as evidenced for
other viruses (16, 28, 45). To further investigate the potential role
of MTs in AAV2 infection, we first examined the colocalization
between virions and MTs in cells. At 30 min or 2 h after pulse
infection with Cy5-AAV2, HeLa cells were fixed with paraformal-
dehyde and MTs were probed with -tubulin antibody. A confo-
cal microscope was used to image the localization of AAV2 parti-
cles on MT filaments (Fig. 4). At 30 min p.i., the majority of AAV2
was localized on the MTs at the cell periphery. At 2 h p.i., about
30% of viral particles were localized on the MTs at the cell periph-
FIG 2 MT disruption does not impair the attachment and internalization of AAV2. HeLa cells were preincubated with DMSO or nocodazole for 30 to 60 min
before pulse infection with Cy5-AAV2. (A) To determine the binding efficiency, cells were harvested at 0 h p.i. for viral genome extraction. The number of viral
genomes per cell (vgs/cell) was determined by quantitative PCR. (B and C) Cells were fixed at 0 h or 1 h p.i. without permeabilization. Nuclei were stained with
DAPI (blue), and AAV2 capsids were stained with monoclonal antibody A20 (green). Before membrane permeabilization, A20 antibody is not able to access the
viral particles inside the cells and thus binds only to the uninternalized AAV2 virions (yellow in the merged figures). (B) Representative images from maximum-
intensity projection (MIP) show the costaining between A20 and Cy5 signals. Several representative uninternalized AAV2 particles are highlighted by arrow-
heads. (C) Quantification of colocalization between Cy5 and A20 as a measurement of viral particles remaining on cell surface and those which have internalized.
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ery, about 50% of viral particles had finished trafficking from the
cell periphery to the perinuclear region, and over 10% of intracel-
lular particles had entered the nucleus (Fig. 4) (55).
Next, we tested whether the role of MTs during AAV infection
is at the step of cytoplasmic trafficking from the cell periphery to
the perinuclear region. To this end, single-particle tracking (SPT)
in live cells was used to study the trafficking of AAV2 in the cyto-
plasm. From previous SPT studies of other viruses, including Ad
and influenza virus (1, 26), it is known that cytoplasmic transpor-
tation is usually characterized by fast and directional movements
on MT filaments. In our SPT experiments with the nontreated
cells, Cy5-AAV2 particles displayed rapid and unidirectional
movements from the cell periphery to the perinuclear region (Fig.
5A and B; see Movie S5 in the supplemental material). This is
different from the bidirectional movement of Ad or HSV on MTs.
Figure 5A suggests that such directed motion is on the MT tracks.
Consistent with previous studies of MT-mediated trafficking (26),
the Cy5-AAV2 particles migrated with instantaneous velocities of
1.5 to 3.5 m/s when moving from the cell periphery to the peri-
nuclear region (Fig. 5C). This movement persisted for only 5 to 10
s (Fig. 5C) and allowed for a large displacement between the initial
and final positions of the particle (Fig. 5D, panel a). Mean square
displacement (MSD) analysis was employed to verify that the ob-
served motion of the Cy5-AAV2 particles is an active transporta-
tion event rather than passive diffusion of virions in the cyto-
plasm. MSD analysis is typically used to describe three types of
particle motions: confined diffusion, normal diffusion, and di-
rected motion (Fig. 6B). Active transportation on MTs is one type
of directed motion, which can be described by a quadratic depen-
dence of MSD on time interval T (Fig. 6B). The MSD-T plot of
the viral particle indicated by arrowheads in Fig. 5A can be fitted
into a quadratic curve, demonstrating that the movement of this
particle is directed motion and is consistent with dynein-mediated
retrograde trafficking on MTs (Fig. 5D, panel b).
Rapid directional motion of AAV2 particles is ablated by MT
disruption. To further verify that such directed movement is me-
diated by MTs, we examined the viral trafficking in the presence of
nocodazole. Videos of viral trafficking were taken at 1 to 1.5 h after
FIG 3 Early perinuclear accumulation and nuclear entry are reduced by the disruption of the MT network. HeLa cells were preincubated with DMSO or
nocodazole at 30 to 60 min before the pulse infection with Cy5-AAV2. Cells were fixed at 0 h or 2 h p.i. Nuclei were stained with DAPI (blue), and MTs were
stained with alpha-tubulin antibody (green). (A) Representative 2D images show the distribution of Cy5-AAV2 particles (red) at 2 h p.i. in the cells treated with
DMSO or nocodazole. (B) Representative images illustrate the quantification of viral distribution using 3D microscopy in the cells treated with DMSO (panels
a to c) or nocodazole (panels d to f) as described previously (55). Panels a and d, top views; panels b to f, magnified side views of the insets in panels a and d; panels
b and e, side views observed above the nucleus (the nuclear envelope is indicated by the blue layer, based on the DAPI signal); panels c and f, side views observed
inside the nucleus (between the top and bottom nuclear envelopes). AAV2 particles in cytoplasm are highlighted as red, these associated with the nuclear envelope
are cyan, and these inside the nucleus are yellow. More details about the viral distribution in these cells are shown in Movies S3 and S4 in the supplemental
material. (C) Percentages of AAV2 particles in the nuclei (panel a) and associated with the nuclear envelope (panel b), calculated from 15 to 20 cells in each group
based on the quantification illustrated in panel B).
FIG 4 AAV2 colocalizes with MTs. Cells were fixed at 30 min (a to d) or 2 h (e)
after pulse infection with Cy5-AAV2. The nucleus was stained with DAPI
(blue), and MTs were stained with alpha-tubulin antibody (green). The local-
ization of Cy5-AAV2 (red) on MTs (green) is shown in panels a and e. Panels
b to d show magnified views of the inset in panel a.
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pulse infection with Cy5-AAV2 particles at about 1 frame per
second (see Movies S6 and S7 in the supplemental material). As
shown in the movies in the supplemental material, compared with
that in control cells, directional movement was completely ablated
in the nocodazole-treated cells (Fig. 6A; see Fig. S5 in the supple-
mental material). Based on MSD plot analysis (Fig. 6B), the di-
rected movement of AAV2 particles indicated by quadratic curve
was observed only in the control cells and not in nocodazole-
treated cells (Fig. 6C). Both normal diffusion characterized by
linear dependence of MSD on T and confined diffusion indi-
cated by asymptotic behavior of MSD on T were not disrupted in
the presence of nocodazole. Particle motions with peak instanta-
neous velocities of over 1.5 m/s were totally lost in the presence
of nocodazole (Fig. 6D, panel a). Correspondingly, particles mo-
tions resulting in large displacement (	10 m) responsible for
particle transportation from the cell periphery to the perinuclear
region were also observed only in the control cells and not in the
cells lacking an intact MT network (Fig. 6D, panel b). The above
data demonstrate that rapid and unidirectional trafficking of
AAV2 from the cell periphery to the perinuclear region requires
intact MTs. Our data also suggest that an intact MT network is
unlikely to be involved in either confined or normal diffusion
(Fig. 6C).
AAV2 migrates on MTs in the endosomes, and the acidifica-
tion of these structures is delayed by MT disruption. After inter-
nalization through clathrin-dynamin-mediated endocytosis, sev-
eral DNA viruses, including parvoviruses, have to escape from the
endosomes upon the acidification of these membranous struc-
tures. It is known that adenovirus (Ad) escapes from the endo-
some in an early stage during infection (within 30 min p.i.) before
these particles migrate on MTs (27, 28). In contrast, little is known
about the timing of endosomal escape and MT-mediated traffick-
ing of parvoviruses. Our electron microscopy data demonstrate
that AAV2 particles were inside the endosomes when migrating
on MTs (Fig. 7A). This observation is the first one to show that
AAV2 particles, in contrast to Ads, usurp the MT-mediated endo-
somal trafficking for their nuclear targeting. It is also known that
the maturation of endosomes takes place during their trafficking
on MTs from the cell periphery to the perinuclear region, where
most mature late endosomes with low pH locate (22, 52). We used
pharmacological studies to further test whether MT-mediated
transportation is required for the acidification of AAV-containing
endosomes. Consistent with an earlier report (2), chemicals (ba-
filomycin and chloroquine) that block endosomal acidification
inhibited AAV transduction (Fig. 7B, panel a). It was demon-
strated previously that adenovirus escapes from early endosomes
FIG 5 Fast and unidirectional movement of AAV2 toward the perinuclear region. Videos were taken at 1 h after pulse infection with Cy5-AAV2 using an
Olympus IX81 inverted fluorescence microscope. (A) Snapshots of consecutive frames with a 2.2-s time interval show the fast and directed movement of
Cy5-AAV2 (purple and indicated by arrowheads) on microtubules (green) toward the perinuclear region. (B) Trajectory of the Cy5-AAV2 particle indicated by
arrowheads in panel A. Frames subject to directional transport are shown as green points and lines, and those with confined motion in the perinuclear region are
indicated as black points. The bar represents 5 m. (C) Instantaneous velocity of the particle (indicated by arrowheads in panel A) over time. (D) The
displacement from the starting position (panel a) and mean square displacement (MSD) (panel b) are plotted for the particle indicated by arrowheads in panel
A. In panel b, the plot between MSD and time interval (T) is fitted by a quadratic curve (dashed line, MSD  0.7269t2  1.902t) with r2  0.9997.
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before migrating on MTs, and its infection is not sensitive to the
inhibition of endosomal acidification as early as 20 to 30 min after
viral inoculation (4, 27). Notably, our data demonstrate that the
infection of most AAV2 particles was still sensitive to bafilomycin
and chloroquine at 1 h p.i. and that these reagents were still able to
partially inhibit (20%) the viral transduction even when added at
2 h p.i. (Fig. 7B, panel a). This observation suggests that some
postentry trafficking events, including MT-mediated migration,
FIG 6 Fast and unidirectional movement of AAV2 particles is dependent on intact microtubules. (A) Representative trajectories for AAV2 in DMSO- or
nocodazole-treated cells as shown in Movies S6 and S7 in the supplemental material. Bars represent 5 m. (B) Three simulated MSD plots for various types of
particle motion. The mean square displacement (MSD) is plotted against time interval T (t). Normal diffusion is usually described by a linear plot given by the
formula MSD  4Dt (D is the diffusion coefficient). Directed motion is usually described by a quadratic curve given by the formula MSD  4Dt  v2t2 (v is the
mean velocity of the motion). An asymptotic behavior with MSD
t (1) indicates confined diffusion. (C) Proportions of viral particles with directed motion
or diffusion from MSD analysis. (D) Maximal instantaneous speed (panel a) and displacement length (panel b) of each AAV2 track. For panels C and D,
trajectories were generated only for these viral particles continuously tracked over 20 frames, and about 40 to 60 trajectories were analyzed for each group.
FIG 7 Association of AAV2-containing endosomes with MTs and delayed endosomal acidification upon MT disruption. (A) AAV2 particles migrate on MTs in
membranous structures. AAV2 particles before (panel a) and after (panel b) labeling of nanogold were demonstrated by TEM. Bar, 20 nm. A micrograph showing the
direct association of AAV-containing endosome with MTs at 1 h after pulse infection of nanogold-labeled AAV2 (panel c) is simplified in a cartoon diagram (panel d).
In the cartoon, MTs are indicated by arrows, the endosome membrane is indicated by closed line, and virus is indicated by arrowheads. Bar, 200 nm. (B) Acidification
of virus-containing endosomes is inhibited by lysosomotropic chemicals at various time points after pulse infection of AAV2 (panel a). At 1 h after pretreatment with
anti-MT drugs (nocodazole and vinblastine), chloroquine was added at 0 h or 3 h after pulse infection of AAV2. To calculate the inhibition of viral transduction, the
expression level of GFP transgene was measured with a flow cytometer and normalized to corresponding treatments without chloroquine (panel b).
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are required for at least a subset, if not all, of the viral particles
before endosomal acidification to allow their escape from the late-
stage endosomes. In concert with this scenario, disruption of MTs
delays the acidification of AAV-containing endosomes and viral
escape, as demonstrated by the data that administration of an-
ti-MT reagents (nocodazole and vinblastine) resulted in an in-
creased inhibition of viral transduction by addition of chloro-
quine at 3 h after pulse infection (Fig. 7B, panel b). This is
consistent with earlier reports that AAV2 was routed to late endo-
somes for infection (9, 11, 55). These results suggest that AAV2
particles traffic on MTs in endosomes from the cell periphery to
the perinuclear region, where acidification of these membranous
structures and viral escape take place.
DISCUSSION
Cytoplasmic trafficking is critical for most DNA viruses to ap-
proach the perinuclear region and deposit their genomic DNA in
the nuclei of host cells. Previous studies have demonstrated that
either actin filaments or microtubules (MTs) are exploited by var-
ious viruses to traverse the dense cytoplasm. For AAV, the exact
mechanism of cytoplasmic trafficking of this virus remains un-
clear, as previous reports have been diametrically opposite in their
conclusions (21, 25, 41). Here we have studied the role of MTs in
AAV2 transduction and have extensively investigated the under-
lying mechanisms of how MTs contribute to viral infection, using
various pharmacological and microscopy tools. Our data from
live-cell imaging and flow cytometry analysis determined the in-
volvement of MTs in AAV2 infection, and the data from quanti-
tative 3D microscopy and quantitative PCR analysis demon-
strated that an intact MT network is required for the nuclear
targeting of AAV but not for cell surface attachment or endocyto-
sis of this virus. In the present study, for the first time we have
determined that the migration of AAV2 on MT tracks is fast (up to
1.5 to 3.5 m/s), which is consistent with dynein-mediated traf-
ficking, and is unidirectional, which is different from the bidirec-
tional motion of Ad or HSV on MTs. In addition, our study using
electron microscopy and pharmacological experiments is the first
one to suggest that AAV traffics on MTs in endosomes and that
acidification of these structures is dependent on an intact MT
network. The findings herein strongly support an as-yet-undocu-
mented model in which after internalization, AAV2 exploits MTs
for fast and unidirectional trafficking in endosomal compart-
ments toward the perinuclear region, where most viral acidifica-
tion events take place. Furthermore, our data that MT disruption
never completely blocks AAV2 transduction suggest the existence
of an alternative, MT-independent trafficking pathway for this
virus. These data together with earlier studies support a model of
AAV2 trafficking during its early infection (Fig. 8) (9, 11, 23, 41).
Both DNA and RNA viruses hijack MTs to achieve productive
infection in host cells. Several parvoviruses, including CPV and
BPV, also have been shown to exploit the MT network for their
transduction (13, 47). However, the role(s) of MTs in AAV infec-
tion remains controversial. To carefully examine the potential ef-
fect of MTs on AAV2 transduction, we employed live-cell imaging
to monitor the dynamics of transgene GFP expression in real time
as a measurement of successful viral transduction. In contrast to
the case in the nontreated cells, where a GFP fluorescence signal
was readily visible as early as 6 h p.i., GFP expression was much
lower in the nocodazole-treated cells and was barely detectable
until 8 h p.i. (Fig. 1A). This result is further confirmed by the flow
cytometry data showing that the expression level of the GFP trans-
gene is lower in MT-disrupted cells than in control cells (Fig. 1B).
These observations are consistent with studies from Englehardt’s
group supporting the involvement of MTs in AAV transduction
(41). In contrast, a previous report concluded that intact MTs
were not involved in AAV infection as measured by the percentage
of GFP-positive cells after inoculation of AAV-GFP (21). Interest-
ingly, we also observed similar proportions of GFP-positive cells
in both nocodazole- and DMSO-treated cells with high viral load-
ing (5,000 to 10,000 vgs/cell), though the GFP signal was much
weaker in nocodazole-treated cells than in control cells (Fig. 1A;
see Fig. S1 in the supplemental material). It is known that only a
few AAV2 particles in the nucleus are needed to turn a cell “green”
(regardless of how faint this “green” is) and thereby for the cell to
be identified by flow cytometry as a “GFP-positive cell” (refer-
ences 5, 9, 24, and 31 and data not shown). In addition, our quan-
titative microscopy data demonstrated that MT disruption only
reduced the nuclear entry of AAV2 and did not completely block
this process (Fig. 3). Under this scenario, it is expected that only a
decreased level of GFP fluorescence intensity and not a decreased
percentage of GFP-positive cells will be observed if the reduced
number of nuclear virions upon MT disruption is still high
enough to turn a cell “green,” which is particularly true when a
high viral dosage is used (Fig. 1; see Fig. S1 in the supplemental
material). As a result, GFP mean fluorescence intensity (MFI) is a
more reliable measurement to assess AAV transduction in this
study. Our data from multiple approaches, including live-cell im-
aging, flow cytometry analysis, and quantitative microscopy, have
strongly suggested that AAV particles exploit the MT network
during their infection. Additionally, MT disruption only reduced
and did not fully block viral transduction and nuclear entry, which
suggests the existence of an alternative but slower trafficking
route(s) in addition to the MT network for AAV infection (Fig. 8).
Exploration of this potential alternative pathway(s) should shed
light on the dynamics of AAV infection in various cell types.
It was previously documented that after being disassembled by
nocodazole or a cold temperature, the MT network can be made to
FIG 8 A model for the role of microtubules in the cytoplasmic trafficking and
endosomal acidification for AAV2 escape. After binding and endocytosis on
the cell surface, AAV2 virions may take two possible trafficking routes toward
the nucleus. Route I, for these internalized at sites distal from the nucleus,
virions migrate on MT tracks in endosomes to traverse the dense cytoplasm
toward the perinuclear regions of host cells. Route II, for these internalized at
sites close to the nucleus, virions in endocytic vesicles can reach the nucleus by
slower MT-independent migration through the cytoplasm between the cyto-
plasmic membrane and nuclear envelope. For both routes, acidification of the
AAV2-containing endosomal compartment happens at the perinuclear region
and allows the escape of viral particles from vesicles, a prerequisite step for
nuclear entry.
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recover to the predrug level by either washing out the drug or
rewarming the cells to 37°C within 10 to 20 min (4). We also
observed the full recovery of the MT network from a cold temper-
ature at about 30 min after incubation at 37°C (data not shown).
Given that the flow cytometry assay was carried out at 10 to 12 h
after pulse infection, the incubation of cells at 4°C for viral binding
should have minimal effects on AAV2 transduction. Consistently,
we did not observe a significant difference between pulse infec-
tions at 4°C and 37°C in regard to the reduction of viral transduc-
tion by nocodazole treatment (Fig. 1; see Fig. S2 in the supplemen-
tal material). To exclude the potential effect of dead cells on the
viral transduction measurement, we washed the cells in each well
three times with PBS before harvesting them for flow cytometry
analysis to remove any floating or loosely attached cells. In this
study, about 95% of cells used for flow cytometry analysis were
viable as demonstrated by multiple methods, including trypan
blue exclusion or 7-aminoactinomycin D (7-AAD) exclusion as-
says (data not shown). The results and conclusions presented in
this study are not influenced by technical concerns such as a con-
tribution of dead cell artifacts.
To specifically study the cytoplasmic trafficking of viral parti-
cles after internalization, we carried out single-particle tracking
(SPT) experiments to trace virions at 1 to 1.5 h after infection (Fig.
5 and 6). Besides technical considerations associated with single-
particle tracking experiments, 1 to 1.5 h p.i. is the better time to
image MT-mediated AAV2 trafficking for two reasons: first, at this
time point, almost all AAV2 particles are internalized (Fig. 2) and
the observation of intracellular trafficking will not be confounded
by the viral motions on the cell surface that typically happen at
earlier time points, and second, the location of the microtubule-
organizing center (MTOC) can be readily visualized by the peri-
nuclear accumulation of AAV particles, which will allow one to
determine if the MT-mediated migration is toward or away from
the perinuclear region. As observed in other SPT studies (1), our
SPT data show that about 8% of viral particles displayed rapid and
directional motions with instantaneous speeds of up to 1.5 to 3.5
m/s during our observation time in the normal cells. The re-
maining virions displayed either normal diffusion (Brownian mo-
tion) or confined diffusion, an indication of movement of AAV in
cytoplasm or actin filaments. As it takes about 2 to 4 h for most
virions to finish trafficking from the cell periphery to the perinu-
clear region (Fig. 4 and data not shown), it is expected that we will
observe only a small subset of particles displaying rapid direc-
tional movements on MTs (each event persists for only 5 to 10 s)
in the limited time window (on the order of a minute) that we can
trace the virions in the single-particle tracking experiment. In ad-
dition, the live imaging allows one to image only a subset of viral
particles on a certain focal plane in the cell, and inevitably the
investigator will lose track of other viral particles moving in the
same cell at a different plane. Furthermore, fast directional mo-
tion may be interrupted by temporary dissociation of the viral
particle from MT tracks or alternatively stalled motors (dynein for
minus-end-directed motion) (29, 50). Under these experimental
limitations, the “8%” from single-particle tracking experiments
does not precisely represent the portion of viral particles migrat-
ing on the MTs during the observation time, not along the entire
viral trafficking period (several hours). Instead, this number is
more to show the existence of MT-mediated fast and directional
movements in the cells, compared with the complete absence of
such motion in MT-disrupted cells. In all, the window of obser-
vation that we utilized, while short in duration, supported the
rapid and unidirectional movement of AAV particles only when
MTs were intact.
Interestingly, compared with those in control cells, AAV2 par-
ticles in a much smaller proportion were still detected in the nuclei
of nocodazole-treated cells (Fig. 3). This is consistent with the
observation in the reporter gene (GFP) assay that AAV2 was still
able to transduce cells in the presence of nocodazole, though at a
reduced level compared with that in control cells (Fig. 1). One
possible reason for this observation is related to the inefficient
MT-independent trafficking of virions. Under this scenario,
AAV2 particles could be internalized in the cell membrane close to
the nucleus, where the virions have to traverse only a small dis-
tance to reach the nucleus (Fig. 8) (29). Movements over such
short distance (several micrometers) might be achieved by normal
diffusion. Internalization in the sites around the nucleus can be
achieved by the direct binding of viral particles at these sites (our
unpublished data) or by viral surfing on the cell membrane to
these sites (34). Our studies do not exclude the possibility that
AAV2 particles may reach the nucleus through a much slower
process by exploiting actin filaments or intermediate filaments
(35, 43). Although it is not uncommon for viruses to exploit mul-
tiple pathways to ensure productive infection, we provide signifi-
cant data to support the role of MTs, whereas other putative path-
ways require further investigation. All these possible scenarios
allow motions with lower velocity and/or directionality toward
the nucleus and are supported by our observation that early AAV
transduction was delayed in the presence of nocodazole (Fig. 1A
and B).
It was also reported that in an in vitro binding assay, cytoplas-
mic dynein can directly bind to AAV2 capsid (25). An interesting
question is whether the rapid directed motion of AAV2 is medi-
ated by the dynein associated with endosomes or by that directly
associated with viral capsid. It is known that AAV2 is internalized
through a clathrin-dynamin-mediated pathway into endosome
compartments (2, 12). While we were not able to definitively de-
termine dynein interaction with AAV-containing endosomes ver-
sus capsids specifically, our data strongly support the usage of this
motor in fast directed movement of AAV. Interestingly, some dy-
nactin subunits, such as p62, were demonstrated to have a mini-
mal impact on dynein-mediated functions and were suggested to
be dispensable for the function of the dynactin complex (37, 42).
More importantly, recent studies have begun to demonstrate that
dynein can directly bind to pathogen-related cargo, and they sug-
gest that dynactin may be dispensable, especially for dynein-me-
diated pathogen trafficking (3, 20, 42). Careful and sophisticated
investigations will be required to address the issues regarding
whether and how the dynactin complex contributes to the MT-
mediated AAV2 trafficking.
It was interesting to note that AAV particles employed endo-
somes for their transportation on MTs up to the perinuclear re-
gion. We have employed electron microscopy analysis to deter-
mine that AAV2 particles are in the endosomal structures when
migrating on MTs (Fig. 7A). It is also known that acidification of
endosomes is essential for escape of AAV2 from vesicles into the
cytoplasm (2, 11). Our pharmacological study indicating that MT
disruption prolonged the sensitivity of AAV2 infection to bafilo-
mycin and chloroquine strongly suggests that prompt acidifica-
tion of AAV-containing endosomal compartment requires intact
MTs (Fig. 7B). These data altogether suggest an undescribed
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model for AAV in which after internalization, AAV2 rapidly and
unidirectionally traffics on MTs in endosomes directly toward pe-
rinuclear sites, where most viral acidification events happen. This
model is in concert with the notion that most acidic endosomes
are localized at perinuclear sites where viruses, such as influenza
virus, escape from these membranous structures (26, 32). This
model is also consistent with the earlier observations that AAV2 is
associated with late endosomes (9) and that viral mutants (VP3-
only and HD/AN) lacking phospholipase activity can be trans-
ported to the perinuclear region indistinguishably from parental
virions (reference 23 and data not shown) but remain noninfec-
tious. Interestingly, AAV’s helper viruses, such as Ad and HSV,
have been shown to exploit a different strategy. Instead of moving
on MTs in membranous structures, both Ad and HSV have to
escape from the endosomes before trafficking on MTs, which is
consistent with their direct interaction with both minus-end-di-
rected and plus-end-directed MT motor proteins, allowing the
bidirectional motions documented for both Ad and HSV on these
filaments (10, 14, 38). Typically, the infection by these viruses is
not sensitive to the inhibition of endosomal acidification by bafi-
lomycin or chloroquine as early as 20 to 30 min after viral inocu-
lation (17). In contrast, AAV particles apparently traffic unidirec-
tionally on MTs, as determined by the interaction between the
virus-containing endosomes and dynein motors (26). Our data
that the majority of AAV2 was still sensitive to both bafilomycin
and chloroquine at 1 h p.i. imply that a more acidic environment
is required for the exposure of Vp1 on viral capsids as well as the
viral escape from these membranous structures (32), compared
with the early escape of Ad and HSV from endosomes at the cell
periphery (27, 44, 45). This result is consistent with the early no-
tions that multiple viral components, including Vp1 and basic
regions on capsid, have to externalize in the endosomes (46). The
observation that 80% of AAV2 was insensitive to bafilomycin and
chloroquine treatments at 2 h p.i. indicates that most virions have
accomplished all these viral actions requiring endosomal acidifi-
cation and even may have escaped from the late endosomes. These
studies together suggest that the rapid directed motion of AAV2
happens when the viral particles are still inside the endosomes. It
should be noted that our data do not exclude the possibility that
some AAV2 can escape from the early endosome as an alternative
pathway in the cells. Given that cytoplasmic dynein can directly
bind to AAV2 capsids in vitro (25, 56), it will be of particular
interest in the future to identify and mutate the dynein binding
sites on AAV2 capsids and further investigate the trafficking of
these mutant capsids. Furthermore, understanding the next steps
of viral entry (i.e., nuclear entry transition from the perinuclear
region) may give critical insights into mechanisms that can be
exploited for more efficient vector transduction.
The findings reported here show that microtubule-dependent
transport plays an essential role in viral transduction, especially
the early onset of transgene expression. Importantly, the data in
this study strongly support an as-yet-undocumented model in
which after internalization, AAV2 exploits fast and unidirectional
transportation on MTs in endosomes directly toward the perinu-
clear region, where acidification of most AAV-containing endo-
somal compartments happens. Validating trafficking pathways in
vivo (55) should allow the research community to enhance the
performance of viral vectors by manipulating intracellular events
as documented in the in vitro studies.
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